Back
Denali Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
50
DNLI
Denali Therapeutics
Last Price:
27.50
Seasonality Move:
18.4%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.72 | Buy |
| 20-day SMA: | 26.88 | Buy |
| 50-day SMA: | 27.32 | Sell |
| 200-day SMA: | 21.76 | Buy |
| 8-day EMA: | 26.8 | Buy |
| 20-day EMA: | 27.05 | Sell |
| 50-day EMA: | 26.68 | Buy |
| 200-day EMA: | 23.68 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 49.75 | Sell |
| Chaikin Money Flow: | 233319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.22 - 28.34) | Sell |
| Bollinger Bands (100): | (22.08 - 27.82) | Buy |
Denali Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 27.05 while DNLI 8-day simple moving average is 26.72, which is a Buy signal.
- The stock price of DNLI is 27.05 while Denali Therapeutics 20-day SMA is 26.88, which makes it a Buy.
- Denali Therapeutics 50-day simple moving average is 27.32 while DNLI share price is 27.05, making it a Sell technically.
- DNLI stock price is 27.05 and Denali Therapeutics 200-day simple moving average is 21.76, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
50
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $27.05. The Score for DNLI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
3.87B
Price in USD:
27.05
Share Volume:
837.2K
Denali Therapeutics 52-Week Range
52-Week High:
32.13
52-Week Low:
14.56
Sell
50
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 27.05 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 27.05 while DNLI 8-day exponential moving average is 26.80, which is a Buy signal.
- The stock price of DNLI is 27.05 while Denali Therapeutics 20-day EMA is 27.05, which makes it a Sell.
- Denali Therapeutics 50-day exponential moving average is 26.68 while DNLI share price is 27.05, making it a Buy technically.
- DNLI stock price is 27.05 and Denali Therapeutics 200-day simple moving average is 23.68, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.54 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting Denali Therapeutics is a Sell
- Denali Therapeutics Relative Strength Index (RSI) is 49.75, which suggest Denali Therapeutics is oversold
- The Bollinger Bands (25) for Denali Therapeutics is (26.22 - 28.34), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (22.08 - 27.82), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.